1. Pastukhov YuF, Ekimova IV, Chesnokova AYu. Molekulyarnye mekhanizmy patogeneza bolezni Parkinsona i perspektivy preventivnoi terapii. In: Ugryumov MV, ed. Neirodegenerativnye zabolevaniya: ot genoma do tselostnogo organizma. vol.1. Moscow: Nauka;2014;309-348. (In Russ.) https://www.rfbr.ru/rffi/ru/books/o_1924061#309
2. Pchelina SN. Alpha-synuclein as a biomarker of Parkinson's disease. Annaly Annaly klinicheskoi i eksperimental'noi nevrologii. 2011;5(4):46-51. (In Russ.) http://annaly-nevrologii.com/wp-content/uploads/2016/09/Stranitsy-iz-Tom-5-4-2011-9.pdf
3. Lewy bodies
4. Grigor'ev IP, Korzhevskii DE. Vnutriyadernye i tsitoplazmaticheskie vklyucheniya nervnykh kletok. In: Korzhevskii DE, ed. Molekulyarnaya neiromorfologiya. Neirodegeneratsiya i otsenka reaktsii nervnykh kletok na povrezhdenie. Sankt-Petersburg: SpetsLit; 2015;50-71. (In Russ.)
5. Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients